We are live on
!
Find out more
CSIC
Clifford Swan Investment Counsel Portfolio holdings
AUM
$2.94B
1-Year Est. Return
21.31%
This Fund
S&P 500
This Quarter
Est. Return
-1.15%
1 Year Est. Return
+21.31%
3 Year Est. Return
+60.82%
5 Year Est. Return
+91.5%
10 Year Est. Return
+310.89%
AUM
$1.49B
AUM Growth
-$29.3M
(-1.9%)
Cap. Flow
-$7.48M
Cap. Flow
% of AUM
-0.5%
Top 10 Holdings %
Top 10 Hldgs %
25.82%
Holding
269
New
8
Increased
47
Reduced
119
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tapestry
TPR
|
+$4.46M |
| 2 |
Gilead Sciences
GILD
|
+$3.59M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$3.55M |
| 4 |
NetApp
NTAP
|
+$3.02M |
| 5 |
State Street DoubleLine Total Return Tactical ETF
TOTL
|
+$2.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$4.56M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$2.79M |
| 3 |
Microsoft
MSFT
|
+$2.19M |
| 4 |
Cisco
CSCO
|
+$1.54M |
| 5 |
GE Aerospace
GE
|
+$1.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.44% |
| 2 | Technology | 16.67% |
| 3 | Healthcare | 13.92% |
| 4 | Consumer Staples | 10.86% |
| 5 | Energy | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Stryker
SYK
$133B
| $18.1M | 1.21% |
188,947
-6,154
| -3% | -$583K |
|
27
ConocoPhillips
COP
$153B
| $18M | 1.21% |
293,784
-2,793
| -0.9% | -$182K |
|
28
eBay
EBAY
$45.5B
| $17.7M | 1.19% |
698,161
-4,280
| -0.6% | -$107K |
|
29
Pfizer
PFE
$150B
| $17.6M | 1.18% |
553,090
-8,660
| -2% | -$282K |
|
30
Franklin Resources
BEN
$17.1B
| $17M | 1.14% |
347,123
+2,896
| +0.8% | +$149K |
|
|
WBA
31
DELISTED
Walgreens Boots Alliance
WBA
| $16.7M | 1.12% |
197,846
-4,595
| -2% | -$396K |
|
32
PepsiCo
PEP
$189B
| $16.6M | 1.11% |
177,656
-2,864
| -2% | -$274K |
|
|
33
Tapestry
TPR
$31.1B
| $16.2M | 1.09% |
468,210
+116,472
| +33% | +$4.46M |
|
34
AbbVie
ABBV
$440B
| $15.6M | 1.05% |
232,083
-4,772
| -2% | -$312K |
|
|
35
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
| $15.5M | 1.04% |
194,210
-57,022
| -23% | -$4.56M |
|
|
36
Cisco
CSCO
$488B
| $14.6M | 0.98% |
531,810
-53,615
| -9% | -$1.54M |
|
37
Abbott
ABT
$192B
| $14.4M | 0.97% |
294,072
-5,080
| -2% | -$244K |
|
38
3M
MMM
$94.8B
| $14.3M | 0.96% |
110,821
-1,829
| -2% | -$245K |
|
39
Qualcomm
QCOM
$171B
| $14.1M | 0.95% |
224,628
+2,321
| +1% | +$158K |
|
40
Edwards Lifesciences
EW
$53.6B
| $13.8M | 0.92% |
579,756
-14,880
| -3% | -$336K |
|
|
41
Alphabet (Google) Class C
GOOG
$4.19T
| $13.2M | 0.89% |
494,840
+132,327
| +37% | +$3.55M |
|
42
Philip Morris
PM
$290B
| $13M | 0.88% |
162,448
-1,816
| -1% | -$149K |
|
43
McDonald's
MCD
$195B
| $12.7M | 0.85% |
133,129
-3,017
| -2% | -$292K |
|
44
RTX Corp
RTX
$300B
| $12.6M | 0.85% |
180,645
+4,859
| +3% | +$357K |
|
|
NVO
45
Novo Nordisk
NVO
$203B
| $12.4M | 0.84% |
454,140
-22,750
| -5% | -$640K |
|
46
Sysco
SYY
$40.5B
| $11.9M | 0.8% |
329,923
-1,100
| -0.3% | -$41.2K |
|
47
Jacobs Solutions
J
$17B
| $10.8M | 0.72% |
320,689
-4,654
| -1% | -$170K |
|
|
BCR
48
DELISTED
CR Bard Inc.
BCR
| $10.7M | 0.72% |
62,844
-2,334
| -4% | -$399K |
|
49
Honeywell
HON
$74.6B
| $10.1M | 0.68% |
109,715
-172
| -0.2% | -$16K |
|
50
Novartis
NVS
$290B
| $9.99M | 0.67% |
113,405
-1,657
| -1% | -$152K |
|
Similar funds
BCF
VGM
MYLI
SCM
CCPM
HCC
NRCM
PHAM
Clifford Swan Investment Counsel's Q2 2015 Portfolio in Review
As of Q2 2015, Clifford Swan Investment Counsel held 269 positions worth $1.49B, down 1.9% from $1.52B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Clifford Swan Investment Counsel's Q2 2015 filing shows 8 new, 47 increased, 119 reduced and 8 closed positions. Its largest new stake was Gilead Sciences: 32,810 shares worth $3.84M. The largest sale was Vanguard Short-Term Corporate Bond ETF, an estimated $4.56M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.
- Clifford Swan Investment Counsel's largest Q2 2015 buy was Gilead Sciences: 32,810 shares worth $3.84M.
- Clifford Swan Investment Counsel added most to Tapestry in Q2 2015, an estimated $4.46M increase.
- Clifford Swan Investment Counsel's biggest Q2 2015 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $4.56M.
- Clifford Swan Investment Counsel fully exited iShares Russell 2000 Growth ETF in Q2 2015, selling an estimated $840K.
- Clifford Swan Investment Counsel's ten largest holdings make up 26% of its $1.49B portfolio in Q2 2015.
- Clifford Swan Investment Counsel opened 8 new positions and closed 8 in Q2 2015.
- Clifford Swan Investment Counsel's portfolio value fell 1.9% quarter-over-quarter to $1.49B.
Based on Clifford Swan Investment Counsel's 13F filing for Q2 2015, filed 11 Aug 2015.